Pomalidomide and Dexamethasone Treatment for ≥ 1 Year in Renally Impaired Patients With Relapsed or Refractory Multiple Myeloma — Katja Weisel (2019) | RDL Network
Paul G. Richardson, Aurore Perrot, Jesús F. San Miguel, Meral Beksaç, Ivan Špıčka, Xavier Leleu, Fredrik Schjesvold, Philippe Moreau, Meletios A Dimopoulos, Shang‐Yi Huang, Jiří Minařík, Michèle Cavo, H. Miles Prince, Sandrine Macé, Rick Zhang, Franck Dubin, Mony Morisse, Kenneth C. Anderson
Yan Li, Xiaomin Wang, Edward O’Mara, Meletios A Dimopoulos, Pieter Sonneveld, Katja Weisel, Jeffrey Matous, David S. Siegel, Jatin J. Shah, Elisabeth Kueenburg, Lars Sternås, Chloe Cavanaugh, Mohamed H. Zaki, Maria Palmisano, Simon Zhou
Antonio Palumbo, Meletios A Dimopoulos, Jesús F. San Miguel, Jean‐Luc Harousseau, Michel Attal, Mohamad A. Hussein, Stefan Knop, Heinz Ludwig, Marie von Lilienfeld‐Toal, Pieter Sonneveld
Meletios A Dimopoulos, K. Weisel, Kevin Song, Michel Delforge, Lionel Karlin, Hartmut Goldschmidt, Philippe Moreau, A. Baños, Albert Oriol, L. Garderet, Michèle Cavo, V. L. Ivanova, Adrían Alegre, Joaquín Martínez‐López, Christopher Chen, Andrew Spencer, Stefan Knop, Nizar J. Bahlis, Christoph Renner, Xin Yu, Kevin Hong, Lars Sternås,
Discussion(0)
No comments yet. Be the first to comment.